Adoptively transferred tumor-specific T cells expanded ex vivo using HSV amplicons encoding 4-1BBL show increased anti-tumor activity in vivo

被引：0

作者：

Yi, Kyung H.

Nechushtan, Hovav

Zhang, Yu

Bowers, William J.

Federoff, Howard J.

Pham, Dien G.

Podack, Eckhard R.

Rosenblatt, Joseph D.

机构：

[1] Univ Miami, Miami, FL USA

[2] Univ Rochester, Rochester, NY USA

来源：

CANCER RESEARCH | 2006年 / 66卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4757

引用

页数：2

共 50 条

[41] NOVEL RNA CAR-T CELLS AGAINST GBM-ASSOCIATED ANTIGEN PTPRZ1 SHOW ANTI-TUMOR EFFICACY BOTH IN VITRO AND IN VIVO
Bedoya, D. Martinez
Davanture, S.
Marinari, E.
Dutoit, V.
Migliorini, D.
HUMAN GENE THERAPY, 2023, 34 (21-22) : A11 - A12
[42] Circulating tumor-reactive CD8+ T cells in melanoma patients contain a CD45RA+CCR7- effector subset exerting ex vivo tumor-specific cytolytic activity
Valmori, D
Scheibenbogen, C
Dutoit, V
Nagorsen, D
Asemissen, AM
Rubio-Godoy, V
Rimoldi, D
Guillaume, P
Romero, P
Schadendorf, D
Lipp, M
Dietrich, PY
Thiel, E
Cerottini, JC
Liénard, D
Keilholz, U
CANCER RESEARCH, 2002, 62 (06) : 1743 - 1750
[43] In vivo anti-tumor activity of murine hematopoietic stem cells expressing a p185HER2-specific chimeric T-cell receptor gene
MICHAEL S FRIEDMAN
MARIANNE T HUBEN
JENNIFER FULLER
ALFRED E CHANG
JAMES J MULE
KEVIN T MCDONAGH
Journal of Microbiology and Immunology, 2006, (02) : 117 - 124
[44] Age-associated increase of IL-6 dampens anti-tumor immune responses through attenuating Th1 differentiation of tumor-specific CD4 T cells
Tsukamoto, Hirotake
Senju, Satoru
Swain, Susan
Nishimura, Yasuharu
JOURNAL OF IMMUNOLOGY, 2014, 192
[45] The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells
Fujisawa, Yasuhiro
Nabekura, Tsukasa
Nakao, Tomohei
Nakamura, Yasuhiro
Takahashi, Takenori
Kawachi, Yasuhiro
Otsuka, Fujio
Onodera, Masafumi
EXPERIMENTAL DERMATOLOGY, 2009, 18 (04) : 396 - 403
[46] Potent Ex Vivo Anti-Tumor Activity in Relapsed Refractory Multiple Myeloma Using Novel DR5-Specific Antibodies with Enhanced Capacity to Form Hexamers upon Target Binding
van der Horst, Hilma J.
Overdijk, Marije B.
Breij, Esther C. W.
Chamuleau, Martine
Lokhorst, Henk M.
Mutis, Tuna
BLOOD, 2017, 130
[47] Adoptively transferred CMV-specific T-cells recognizing dominant and sub-dominant pp65 epitopes demonstrate improved in vivo inhibition of tumor xenografts in combination with PD-1 inhibition
Hasan, Aisha N.
Selvakumar, Annamalai
Kuo, Tzu-Yun
O'Reilly, Richard J.
CANCER RESEARCH, 2017, 77
[48] RNA-Based Gene Writer and Lipid Nanoparticle (LNP) Delivery Enables Generation of Functional Chimeric Antigen Receptor (CAR) T Cells with In Vitro and In Vivo Anti-Tumor Activity and T Cell-Specific Genome Engineering In Vivo
Venugopal, Kartika
Magee, Michael
De Iaco, Alberto
Rodriguez, Jason
Rottman, James
Li, Donghui
Schiroli, Giulia
Cao, Yu
Levy, Rebecca
Schute, Travis
Gupta, Mohit
Ferren, Christina
Monte, Michael
Wang, Jane
Querbes, Bill
Cotta-Ramusino, Cecilia
Peshwa, Madhusudan V.
Holmes, Michael C.
MOLECULAR THERAPY, 2024, 32 (04) : 7 - 8
[49] BI 836909, a Novel Bispecific T Cell Engager for the Treatment of Multiple Myeloma Induces Highly Specific and Efficacious Lysis of Multiple Myeloma Cells in Vitro and Shows Anti-Tumor Activity in Vivo
Hipp, Susanne
Deegen, Petra
Wahl, Joachim
Blanset, Diann
Thomas, Oliver
Rattel, Benno
Adam, Paul
Friedrich, Matthias
BLOOD, 2015, 126 (23)
[50] Induction of anti-tumor immunity ex-vivo using dendritic cells transduced with fowl pox vector expressing MUC-1 and a triad of costimulatory molecules (PANVAC-F)
Vasir, Baldev
Lenahan, Corrine
Bissonnette, Adam
Rosenblatt, Jacalyn
Wu, Zekui
Kufe, Donald
Avigan, David
JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 903 - 903

← 1 2 3 4 5 →